INBRED RAT STRAIN COMPARISONS INDICATE DIFFERENT SITES OF ACTION FOR COCAINE AND AMPHETAMINE LOCOMOTOR STIMULANT EFFECTS

被引:74
作者
GEORGE, FR
PORRINO, LJ
RITZ, MC
GOLDBERG, SR
机构
[1] NIDA,ADDICT RES CTR,PRECLIN PHARMACOL BRANCH,BALTIMORE,MD 21224
[2] NINCDS,BRAIN IMAGING UNIT,BETHESDA,MD 20892
关键词
LOCOMOTOR ACTIVITY; COCAINE; AMPHETAMINE; BEHAVIOR GENETICS; RATS; DOPAMINERGIC-D1; DOPAMINERGIC-D2; DOPAMINE UPTAKE;
D O I
10.1007/BF02245649
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Cocaine and amphetamine produce several behavioral effects, most notably locomotor stimulation. Biochemically, evidence suggests specific involvement of dopaminergic systems, although not necessarily identical sites, in mediating cocaine- and amphetamine-induced locomotor stimulation. This study examined the effects of cocaine or amphetamine on locomotor activity in rats from the ACI, F344, LEW and NBR inbred strains. Dose-dependent increases in locomotor activity were found for both drugs in all strains. However, large potency and efficacy differences were found. Further, significant strain by drug interactions were found, in that the strain rank order for stimulant response to the two drugs was not identical. Since striatal dopaminergic neurons influence locomotor activity, we also assessed ligand affinity and receptor density of dopamine transporters and dopaminergic D1 and D2 receptors in striatal tissue from these same strains of rats. No differences in these receptor binding parameters were found. These findings support the conclusion that these two drugs produce their locomotor stimulant effects through different sites of action, and that genetic differences in response to these drugs at the behavioral level do not appear to be mediated significantly by differences in structure or number of striatal dopaminergic sites. The further use of genetic methods, however, may aid in determining the specific sites of action of these widely used stimulant drugs.
引用
收藏
页码:457 / 462
页数:6
相关论文
共 47 条
[21]   COCAINE PRODUCES LOW-DOSE LOCOMOTOR DEPRESSANT EFFECTS IN MICE [J].
GEORGE, FR .
PSYCHOPHARMACOLOGY, 1989, 99 (02) :147-150
[22]   COCAINE PRODUCES LOCOMOTOR STIMULATION IN SS-MICE BUT NOT LS-MICE - RELATIONSHIP TO DOPAMINERGIC FUNCTION [J].
GEORGE, FR ;
RITZ, MC .
PSYCHOPHARMACOLOGY, 1990, 101 (01) :18-22
[23]  
GONZALEZ FA, 1977, J PHARMACOL EXP THER, V201, P33
[24]   STUDIES ON DISTINCTION BETWEEN UPTAKE INHIBITION AND RELEASE OF [H-3] DOPAMINE IN RAT-BRAIN TISSUE-SLICES [J].
HEIKKILA, RE ;
ORLANSKY, H ;
COHEN, G .
BIOCHEMICAL PHARMACOLOGY, 1975, 24 (08) :847-852
[25]  
HEIKKILA RE, 1975, J PHARMACOL EXP THER, V194, P47
[26]   GUANINE-NUCLEOTIDE REGULATION OF AGONIST INTERACTIONS AT [H-3] SCH23390-LABELED D1 DOPAMINE-RECEPTORS IN RAT STRIATUM [J].
HESS, EJ ;
BATTAGLIA, G ;
NORMAN, AB ;
IORIO, LC ;
CREESE, I .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1986, 121 (01) :31-38
[27]   DOPAMINE IN MESOLIMBIC SYSTEM OF RAT-BRAIN - ENDOGENOUS LEVELS AND EFFECTS OF DRUGS ON UPTAKE MECHANISM AND STIMULATION OF ADENYLATECYCLASE ACTIVITY [J].
HORN, AS ;
CUELLO, AC ;
MILLER, RJ .
JOURNAL OF NEUROCHEMISTRY, 1974, 22 (02) :265-270
[28]   COMPARATIVE DISCRIMINATIVE STIMULUS PROPERTIES OF DL-CATHINONE, D-AMPHETAMINE, AND COCAINE IN RATS [J].
HUANG, D ;
WILSON, MC .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1986, 24 (02) :205-210
[29]  
JAVITCH JA, 1984, MOL PHARMACOL, V26, P35
[30]  
KALIVAS PW, 1988, J PHARMACOL EXP THER, V245, P485